Intercepting Pancreatic Cancer: Our Dream Teamʼs Resolve to Stop Pancreatic Cancer
During its inaugural year, the Stand Up to Cancer Pancreatic Interception Dream Team kicked off initiatives in a targeted effort to revolutionize the outcomes of those at risk for developing pancreatic cancer. Our multidisciplinary effort spans six institutions (MD Anderson Cancer Center, Johns Hopk...
Main Author: | Jacks, Tyler E |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | English |
Published: |
Ovid Technologies (Wolters Kluwer Health)
2020
|
Online Access: | https://hdl.handle.net/1721.1/126156 |
Similar Items
-
Survival of pancreatic cancer cells lacking KRAS function
by: Noll, Elisa M., et al.
Published: (2017) -
Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006) -
Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer
by: Tao, Zhimin, et al.
Published: (2022) -
Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer
by: Tao, Zhimin, et al.
Published: (2021) -
Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
by: Chen, Pan-Yu, et al.
Published: (2020)